The impact of antimicrobial resistance on the treatment of sexually transmitted diseases

被引:16
作者
Erbelding, E [1 ]
Quinn, TC [1 ]
机构
[1] JOHNS HOPKINS UNIV,SCH MED,DIV INFECT DIS,BALTIMORE,MD 21205
关键词
D O I
10.1016/S0891-5520(05)70396-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The focus of this article is to review the development of antimicrobial resistance among several sexually transmitted diseases (STDs) and to discuss the frequency and mechanisms of resistance and recommendations for treatment of selected STDs in which resistance to certain antimicrobial agents has increased. For a number of STDs, such as Chlamydia trachomatis and syphilis, no evidence of antimicrobial resistance has developed over the years, although management of these diseases, such as in the case of pelvic inflammatory disease or syphilis in MV-infected individuals, requires intensive treatment and follow-up to ensure effectiveness of treatment.
引用
收藏
页码:889 / &
页数:16
相关论文
共 60 条
[1]  
ALBRITTON WL, 1989, ANTIMICROB AGENTS CH, V25, P187
[2]  
[Anonymous], 1997, HIDDEN EPIDEMIC CONF
[3]  
BARTLETT JG, 1996, POCKETBOOK INFECT DI, P16
[4]  
BIRLEY H, 1994, GENITOURIN MED, V70, P292
[5]  
CATES W, 1990, EPIDEMIOLOGY CONTROL, P409
[6]  
*CDCP, 1996, MMWR-MORBID MORTAL W, V45, P883
[7]  
*CDCP, 1983, MMWR-MORBID MORTAL W, V32, P273
[8]  
*CDCP, 1996, SEX TRANSM DIS SURV
[9]  
Centers for Disease Control and Prevention, 1972, Morb Mortal Wkly Rep, V21, P82
[10]  
Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P761